The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Changing patterns in the epidemiology of β‐thalassemia
Open accessAbstract
β‐thalassemia major is an inherited hemoglobinopathy that requires lifelong red blood cell transfusions and iron chelation therapy to prevent complications due to iron overload. Traditionally, β‐thalassemia has been more common in certain regions of the world such as the Mediterranean, Middle East, and Southeast Asia. However, the prevalence of β‐thalassemia is increasing in other regions, including Northern Europe and North America, primarily due to migration. This review summarizes the available data on the changing incidence and prevalence of β‐thalassemia as well as factors influencing disease frequency. The data suggest that the epidemiology of β‐thalassemia is changing: Migration has increased the prevalence of the disease in regions traditionally believed to have a low prevalence, while, at the same time, prevention and screening programs in endemic regions have reduced the number of affected individuals. Various approaches to prevention and screening have been used. Region‐specific prevention and treatment programs, customized to align with local healthcare resources and cultural values, have been effective in identifying patients and carriers and providing information and care. Significant challenges remain in universally implementing these programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global epidemiology of haemoglobin disorders and derived service indicators
Modell, B. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.06.036673 · Cited by 1,924
United Nations High Commissioner for Refugees (UNHCR)
(2014) · International Year Book and Statesmen's Who's Who · doi:10.1163/1570-6664_iyb_sim_org_40277 · Cited by 1,489
Galanello, R., & Origa, R. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-11 · Cited by 1,466
Borgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,119
Self-citationPhenotype-genotype relationships in monogenic disease: lessons from the thalassaemias
Weatherall, D. J. (2001) · Nature Reviews Genetics · doi:10.1038/35066048 · Cited by 692
Modell, B., Khan, M., Darlison, M., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-42 · Cited by 600
Complications of β-thalassemia major in North America
Cunningham, M. J., Macklin, E. A., Neufeld, E. J., Cohen, A. R., & the Thalassemia Clinical Research Network (2004) · Blood · doi:10.1182/blood-2003-09-3167 · Cited by 454
Survival and Complications in Thalassemia
BORGNA‐PIGNATTI, C., CAPPELLINI, M. D., DE STEFANO, P., DEL VECCHIO, G. C., FORNI, G. L., GAMBERINI, M. R., GHILARDI, R., ORIGA, R., PIGA, A., ROMEO, M. A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.006 · Cited by 426
Self-citationIranian national thalassaemia screening programme
Samavat, A., & Modell, B. (2004) · BMJ · doi:10.1136/bmj.329.7475.1134 · Cited by 284
β-thalassemia distribution in the old world: a historical standpoint of an ancient disease
De Sanctis, V. (2017) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2017.018 · Cited by 277
IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
Kountouris, P., Lederer, C. W., Fanis, P., Feleki, X., Old, J., & Kleanthous, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103020 · Cited by 270
The prevalence of thalassemia in mainland China: evidence from epidemiological surveys
Lai, K., Huang, G., Su, L., & He, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00967-2 · Cited by 217
Telfer, P. T., Coen, P. G., Christou, S., Hadjigavriel, M., Kolnakou, A., Pangalou, E., Pavlides, N., Psiloines, M., Simamonian, K., Skordos, G., et al. (2006) · PubMed · Cited by 190
(1996) · PubMed Central · Cited by 165
Newborn screening for hemoglobinopathies in California
Michlitsch, J., Azimi, M., Hoppe, C., Walters, M. C., Lubin, B., Lorey, F., & Vichinsky, E. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21883 · Cited by 164
Saffi, M., & Howard, N. (2015) · Public Health Genomics · doi:10.1159/000430837 · Cited by 159
Epidemiology of haemoglobin disorders in Europe: an overview
Modell, B., Darlison, M. W., Birgens, H., et al. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601046557 · Cited by 155
Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease
Vichinsky, E. P., Macklin, E. A., Waye, J. S., Lorey, F., & Olivieri, N. F. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0843 · Cited by 131
Tan, J. A. M. A., Lee, P.-C., Wee, Y., Tan, K., Mahali, N. F., George, E., & Chua, K. H. (2010) · BioMed Research International · doi:10.1155/2010/706872 · Cited by 119
Haemoglobinopathies in Europe: health & migration policy perspectives
Martinez, P. A., Angastiniotis, M., Eleftheriou, A., et al. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-97 · Cited by 103
Thuret, I., Pondarré, C., Loundou, A., Steschenko, D., Girot, R., Bachir, D., Rosé, C., Barlogis, V., Donadieu, J., de Montalembert, M., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.018051 · Cited by 101
Increasing prevalence of thalassemia in America: Implications for primary care
Sayani, F. A., & Kwiatkowski, J. L. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1091942 · Cited by 91
Angastiniotis, M., Corrons, J. V., Soteriades, E. S., & Eleftheriou, A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/727905 · Cited by 88
Kwiatkowski, J. L., Kim, H.-Y., Thompson, A. A., Quinn, C. T., Mueller, B. U., Odame, I., Giardina, P. J., Vichinsky, E. P., Boudreaux, J. M., Cohen, A. R., et al. (2012) · Blood · doi:10.1182/blood-2011-04-344507 · Cited by 88
on behalf of the Greek Haemoglobinopathies Study Group, Voskaridou, E., Ladis, V. A., Kattamis, A., Hasapopoulou, E., Economou, M. P., Kourakli, A., Maragkos, K., Kontogianni, K., Lafioniatis, S., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1465-7 · Cited by 85
Self-citationAudit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years
Modell, B., Petrou, M., Layton, M., Slater, C., Ward, R. H. T., Rodeck, C. H., Varnavides, L., Nicolaides, K. H., Gibbons, S., Fitches, A. C., et al. (1997) · BMJ · doi:10.1136/bmj.315.7111.779 · Cited by 81
Iron chelation therapy in the management of thalassemia: the Asian perspectives
Viprakasit, V., Lee-Lee, C., Chong, Q. T., Lin, K., & Khuhapinant, A. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0432-0 · Cited by 80
Self-citationBadens, C., Joly, P., Agouti, I., Thuret, I., Gonnet, K., Fattoum, S., Francina, A., Siméoni, M.-C., Loundou, A., & Pissard, S. (2011) · Haematologica · doi:10.3324/haematol.2011.046748 · Cited by 78
Progress Toward the Control and Management of the Thalassemias
Fucharoen, S., & Weatherall, D. J. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.12.001 · Cited by 77
Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
Alkindi, S. S. A., Zadjali, S. A., Madhani, A. A., Daar, S., Al-Haddabi, H., Abri, Q. A., Gravell, D., Berbar, T., Pravin, S., Pathare, A. V., et al. (2010) · Hemoglobin · doi:10.3109/03630261003677213 · Cited by 74
on behalf of the Greek Haemoglobinopathies Study Group, Voskaridou, E., Kattamis, A., Fragodimitri, C., Kourakli, A., Chalkia, P., Diamantidis, M. D., Vlachaki, E., Drosou, M., Lafioniatis, S., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3493-4 · Cited by 70
Self-citationNational registry of hemoglobinopathies in Spain (REPHem)
Cela, E., Bellón, J. M., de la Cruz, M., Beléndez, C., Berrueco, R., Ruiz, A., Elorza, I., de Heredia, C. D., Cervera, Á., Vallès, G., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26322 · Cited by 57
Lin, M., Zhong, T., Chen, Y., Wang, J., Wu, J.-R., Lin, F., Tong, X., Yang, H.-T., Hu, X., Hu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101505 · Cited by 52
Newborn screening for non-sickling hemoglobinopathies
Hoppe, C. C. (2009) · Hematology · doi:10.1182/asheducation-2009.1.19 · Cited by 51
Kountouris, P., Kousiappa, I., Papasavva, T., Christopoulos, G., Pavlou, E., Petrou, M., Feleki, X., Karitzie, E., Phylactides, M., Fanis, P., et al. (2016) · Scientific Reports · doi:10.1038/srep26371 · Cited by 50
State-based surveillance for selected hemoglobinopathies
Hulihan, M., Feuchtbaum, L., Jordan, L. B., Kirby, R. S., Snyder, A., Young, W., Greene, Y., Telfair, J., Wang, Y., Cramer, W., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.81 · Cited by 48
Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated
Kim, S., & Tridane, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170485 · Cited by 42
Economic Burden of Thalassemia Major in Iran, 2015.
Esmaeilzadeh, F., Azarkeivan, A., Emamgholipour, S., Sari, A. A., Yaseri, M., Ahmadi, B., & Ghaffari, M. (2016) · PubMed Central · Cited by 40
Thalassemia Major: Transplantation or Transfusion and Chelation
Mohamed, S. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.022 · Cited by 38
Ladis, V., Chouliaras, G. L., Berdoukas, V. A., Moraitis, P., Zannikos, K., Berdoussi, E., & KATTAMIS, C. A. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01491.x · Cited by 28
Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis
Giambona, A., Damiani, G., Vinciguerra, M., Jakil, C., Cannata, M., Cassarà, F., Picciotto, F., Schillaci, G., Cigna, V., Renda, D., et al. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12628 · Cited by 25
Erdem, A. Y., Yenigürbüz, F. D., Pekpak, E., Akıncı, B., Aktekin, E., Bayram, C., Yıldırmak, Z. Y., Ataseven, E., Akbayram, S., Şaşmaz, İ., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27636 · Cited by 23
Screening for thalassemia and hemoglobinopathy in a rural area of Thailand: a preliminary study.
Nathalang, O., Nillakupt, K., Arnutti, P., Boonsiri, T., Panichkul, S., & Areekul, W. (2005) · PubMed · Cited by 20
Carrier detection for beta-thalassemia trait in general Pakistani population: a way forward
Ali, N. B., Moiz, B., Azhar, W. B., et al. (2012) · Hematology · doi:10.1179/1607845412y.0000000002 · Cited by 20
Analysis of survival data in thalassemia patients in Shiraz, Iran
Rajaeefard, A., Hajipour, M., Tabatabaee, H. R., et al. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015031 · Cited by 17
Prevalence of Anemia and Hemoglobin Disorders Among School Children in Myanmar
Wah, S. T., Yi, Y. S., Khin, A. A., Plabplueng, C. D., & Nuchnoi, P. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1289103 · Cited by 16
The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan
Wang, H., Hsieh, L., Liu, Y., Hsiao, H., Lin, S.-K., Tsai, W., & Liu, T. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2868-7 · Cited by 14
A Pilot Beta-Thalassaemia Screening Program in the Albanian Population for a Health Planning Program
Baghernajad-Salehi, L., D’Apice, M. R., Babameto-Laku, A., Biancolella, M., Mitre, A., Russo, S., Daniele, N. D., Sangiuolo, F. C., Mokini, V., & Novelli, G. (2009) · Acta Haematologica · doi:10.1159/000226423 · Cited by 11
Haemoglobinopathies and β -Thalassaemia among the Tribals Working in the Tea Gardens of Assam, India
Teli, A. B. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/22010.9002 · Cited by 11
Topal, Y., Topal, H., Ceyhan, M. N., Azik, F. M., Çapanoğlu, M., & Kocabaş, C. N. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1046185 · Cited by 9
Cited by
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2021838 · Cited by 477
Kattamis, A., Kwiatkowski, J. L., & Aydinok, Y. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00536-0 · Cited by 313
Self-citationTuo, Y., Li, Y., Li, Y., Ma, J., Yang, X., Wu, S., Jin, J., & He, Z. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102619 · Cited by 283
Fu, Y.-K., Liu, H.-M., Lee, L.-H., Chen, Y.-J., Chien, S.-H., Lin, J.-S., Chen, W.-C., Cheng, M.-H., Lin, P.-H., Lai, J.-Y., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11091725 · Cited by 38
Metadata
- Authors
- Kattamis, A., Forni, G. L., Aydinok, Y., & Viprakasit, V.
- Venue
- European Journal of Haematology
- Publisher
- Wiley
- Published
- 2020-09-21
- Volume
- 105
- Issue
- 6
- Pages
- 692-703
- ISSN
- 0902-4441 (ISSN-L)
- 1600-0609
- OpenAlex
- W3083542131
- Cited by
- 331
- References
- 50
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.